We are live on ! Find out more
Barclays

Barclays Portfolio holdings

AUM $416B
1-Year Est. Return 33.63%
 

Barclays PLC, founded in 1690 by goldsmith bankers in London, is a British multinational financial institution headquartered in London, operating as one of the world’s oldest banks with a significant presence in investment banking, retail banking, and wealth management. Managing billions in assets, Barclays serves millions of customers globally through its retail arm (notably in the UK) and its investment banking division, which excels in trading, mergers and acquisitions, and capital markets, competing with Wall Street giants. The bank has navigated challenges like the 2008 financial crisis—opting for private funding over a government bailout—and has since focused on restructuring, digital innovation, and sustainable finance initiatives. With a rich history and a modern global footprint, Barclays remains a key player in both UK and international financial markets.

This Fund
S&P 500
This Quarter Est. Return
+6.17%
1 Year Est. Return
+33.63%
3 Year Est. Return
+104.86%
5 Year Est. Return
+133.18%
10 Year Est. Return
+557.96%
AUM
$144B
AUM Growth
+$27.9B
Cap. Flow
+$22.2B
Cap. Flow %
15.4%
Top 10 Hldgs %
31.02%
Holding
7,740
New
680
Increased
3,884
Reduced
2,259
Closed
408

Sector Composition

Rank Sector Weight
1 Technology 8.24%
2 Financials 5.68%
3 Healthcare 5.62%
4 Consumer Discretionary 5.04%
5 Industrials 3.95%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
RUBY
5376
DELISTED
Rubius Therapeutics, Inc
RUBY
$109K ﹤0.01%
+4,555
New +$104K
CCBG icon
5377
Capital City Bank Group
CCBG
$888M
$108K ﹤0.01%
4,606
+3,771
+452% +$92.1K
UUUU icon
5378
Energy Fuels
UUUU
$3.69B
$108K ﹤0.01%
32,982
+27,524
+504% +$81.3K
APRN
5379
CALL
DELISTED
Blue Apron Holdings, Inc. Class A Common Stock
APRN
$108K ﹤0.01%
350
-766
-69% -$335K
USX
5380
DELISTED
U.S. Xpress Enterprises, Inc. Class A Common Stock
USX
$108K ﹤0.01%
7,848
+6,848
+685% +$99.5K
BLMT
5381
DELISTED
BSB Bancorp, Inc.
BLMT
$108K ﹤0.01%
3,326
+2,610
+365% +$88.2K
HEDJ icon
5382
PUT
WisdomTree Europe Hedged Equity Fund
HEDJ
$1.87B
$107K ﹤0.01%
3,400
-2,800
-45% -$89.8K
LITS
5383
Lite Strategy Inc
LITS
$30.7M
$107K ﹤0.01%
+1,240
New +$101K
RDI icon
5384
Reading International Class A
RDI
$33.2M
$107K ﹤0.01%
6,748
+3,096
+85% +$49.3K
UYG icon
5385
ProShares Ultra Financials
UYG
$849M
$107K ﹤0.01%
2,478
+966
+64% +$42.5K
SRAX
5386
DELISTED
SRAX, Inc. Class A Common Stock
SRAX
$107K ﹤0.01%
28,700
AMBR
5387
DELISTED
Amber Road Inc
AMBR
$107K ﹤0.01%
11,208
+4,523
+68% +$40.3K
AFSI
5388
PUT
DELISTED
AmTrust Financial Services, Inc.
AFSI
$107K ﹤0.01%
7,400
CROX icon
5389
CALL
Crocs
CROX
$6.31B
$106K ﹤0.01%
5,000
+2,700
+117% +$51.9K
AAIC
5390
DELISTED
Arlington Asset Investment Corp.
AAIC
$106K ﹤0.01%
11,265
+1,618
+17% +$16.5K
FRC
5391
CALL
DELISTED
First Republic Bank
FRC
$106K ﹤0.01%
+1,100
New +$111K
HMTV
5392
DELISTED
Hemisphere Media Group, Inc.
HMTV
$106K ﹤0.01%
7,625
+5,705
+297% +$74.6K
PFPT
5393
PUT
DELISTED
Proofpoint, Inc.
PFPT
$106K ﹤0.01%
+1,000
New +$116K
FFEU
5394
DELISTED
Barclays ETN+ FI Enhanced Europe 50 ETN Series C
FFEU
$106K ﹤0.01%
+1,113
New +$108K
APVO icon
5395
Aptevo Therapeutics
APVO
$5.16M
0
ARCC icon
5396
PUT
Ares Capital
ARCC
$14.3B
$105K ﹤0.01%
+6,100
New +$105K
ATLO icon
5397
AMES National
ATLO
$280M
$105K ﹤0.01%
3,827
+3,198
+508% +$95.8K
CCEP icon
5398
PUT
Coca-Cola Europacific Partners
CCEP
$47.1B
$105K ﹤0.01%
2,300
+2,000
+667% +$85.2K
FBRX icon
5399
Forte Biosciences
FBRX
$1.58B
$105K ﹤0.01%
18
+14
+350% +$53.3K
ITA icon
5400
iShares US Aerospace & Defense ETF
ITA
$15B
$105K ﹤0.01%
972

Similar funds

Barclays's Q3 2018 Portfolio in Review

As of Q3 2018, Barclays held 7,740 positions worth $144B, up 24% from $116B the previous quarter. Its ten largest holdings account for 31% of the portfolio.

Barclays deployed $22.2B of net new capital in Q3 2018, opening 680 new positions and adding to 3,884 existing holdings. Its largest new stake was iPath Series B S&P GSCI Crude Oil ETN: 5,000,000 shares worth $75.7M.

By sector, the portfolio is most concentrated in Technology at 8.2% of assets, up from 7.4% a quarter earlier, followed by Financials and Healthcare.

On the sell side, the largest reduction was Weyerhaeuser, an estimated $431M trimmed.

  • Barclays's largest Q3 2018 buy was iPath Series B S&P GSCI Crude Oil ETN: 5,000,000 shares worth $75.7M.
  • Barclays added most to Fortive in Q3 2018, an estimated $1.27B increase.
  • Barclays's biggest Q3 2018 reduction was Weyerhaeuser, cutting an estimated $431M.
  • Barclays fully exited Validus Hold Ltd in Q3 2018, selling an estimated $71M.
  • Barclays's ten largest holdings make up 31% of its $144B portfolio in Q3 2018.
  • Barclays opened 680 new positions and closed 408 in Q3 2018.
  • Barclays's portfolio value rose 24% quarter-over-quarter to $144B.

Based on Barclays's 13F filing for Q3 2018, filed 14 Nov 2018.